Carlos Eduardo dos Santos Ferreira1, Carolina Nunes França2, Cassyano Januário Correr3, Márcia L Zucker4, Adagmar Andriolo5, Marileia Scartezini3. 1. Hospital Israelita Albert Einstein, São Paulo, SP, Brazil; Federal University of São Paulo - UNIFESP, São Paulo, Brazil. Electronic address: carlos.ferreira@einstein.br. 2. Federal University of São Paulo - UNIFESP, São Paulo, Brazil; University of Santo Amaro - UNISA, São Paulo, Brazil. 3. Federal University of Paraná, Curitiba, Brazil. 4. ZIVD, LLC, Metuchen, NJ, USA. 5. Federal University of São Paulo - UNIFESP, São Paulo, Brazil.
Abstract
BACKGROUND: We evaluated the clinical correlation between the CardioChek PA analyzer and a clinical laboratory reference method to use for screening program purposes. METHODS: Fasting blood samples were collected on 516 patients (age 20-85 y). One venous sample was collected using a serum tube for the evaluation on a COBAS reference analyzer. A second venous sample was collected in a lithium heparin tube and was evaluated on the CardioChek PA analyzer (CCPA venous). A fingerstick sample (CCPA fingerstick) was evaluated only on the CardioChek PA analyzer. Linear regression analyses were performed for each measured analyte, total cholesterol, HDL-cholesterol and triglycerides. RESULTS: The correlation between the CCPA fingerstick and CCPA venous was extremely high for HDL-C and triglycerides, and good for total cholesterol. Our results demonstrated a good clinical agreement for total cholesterol, HDL-C and triglycerides between 97.7% and 94.6% in the comparison of the CCPA to the reference analyzer. CONCLUSIONS: We identified the pre-analytic phase as an important step to guarantee the quality of results and indicate that the CardioChek PA is a reliable lipid point-of-care testing system that can be used for the application of clinical screening anywhere.
BACKGROUND: We evaluated the clinical correlation between the CardioChek PA analyzer and a clinical laboratory reference method to use for screening program purposes. METHODS: Fasting blood samples were collected on 516 patients (age 20-85 y). One venous sample was collected using a serum tube for the evaluation on a COBAS reference analyzer. A second venous sample was collected in a lithium heparin tube and was evaluated on the CardioChek PA analyzer (CCPA venous). A fingerstick sample (CCPA fingerstick) was evaluated only on the CardioChek PA analyzer. Linear regression analyses were performed for each measured analyte, total cholesterol, HDL-cholesterol and triglycerides. RESULTS: The correlation between the CCPA fingerstick and CCPA venous was extremely high for HDL-C and triglycerides, and good for total cholesterol. Our results demonstrated a good clinical agreement for total cholesterol, HDL-C and triglycerides between 97.7% and 94.6% in the comparison of the CCPA to the reference analyzer. CONCLUSIONS: We identified the pre-analytic phase as an important step to guarantee the quality of results and indicate that the CardioChek PA is a reliable lipid point-of-care testing system that can be used for the application of clinical screening anywhere.
Authors: Sujay S Kakarmath; Rachel M Zack; Germana H Leyna; Saman Fahimi; Enju Liu; Wafaie W Fawzi; Zohra Lukmanji; Japhet Killewo; Frank Sacks; Goodarz Danaei Journal: BMJ Open Date: 2017-06-06 Impact factor: 2.692
Authors: Mahmoud M A Abulmeaty; Ali M Almajwal; Najwa K Almadani; Mona S Aldosari; Ahmed A Alnajim; Saeed B Ali; Heba M Hassan; Hany A Elkatawy Journal: Saudi Med J Date: 2017-04 Impact factor: 1.484
Authors: Thomas A Gaziano; Shafika Abrahams-Gessel; F Xavier Gomez-Olive; Alisha Wade; Nigel J Crowther; Sartaj Alam; Jennifer Manne-Goehler; Chodziwadziwa W Kabudula; Ryan Wagner; Julia Rohr; Livia Montana; Kathleen Kahn; Till W Bärnighausen; Lisa F Berkman; Stephen Tollman Journal: BMC Public Health Date: 2017-02-17 Impact factor: 3.295
Authors: Melinda J Hutchesson; Robin Callister; Philip J Morgan; Ilung Pranata; Erin D Clarke; Geoff Skinner; Lee M Ashton; Megan C Whatnall; Mark Jones; Christopher Oldmeadow; Clare E Collins Journal: Healthcare (Basel) Date: 2018-05-02